This report recognizes the top 50 thought-leaders in orphan drugs and rare disease.
The thought-leaders include representatives from industry, patient advocacy groups, research institutions, government and media from around the world.
They were selected based on the following criteria:
- Research & methodology
- Awards & recognition
- Community engagement & impact
Download a copy of the report today to find out who is pioneering orphan drug research, awareness and legislation.
You may also be interested in participating at World Orphan Drug Congress USA on April 23-25, 2014. World Orphan Drug Congress USA is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. Download the prospectus here for more information.